Legend Biotech Corp (LEGN) — Cash Flow Reinvestment Rate
Legend Biotech Corp (LEGN) has a Cash Flow Reinvestment Rate of 0.87x as of September 2025, reinvesting $25.01 Million (capex $5.00 Million plus investments $-20.00 Million) from operating cash flow of $28.80 Million. Check LEGN cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Legend Biotech Corp Cash Flow Reinvestment Rate (2018–2018)
Historical reinvestment intensity for Legend Biotech Corp across 1 annual periods. Explore long-term investment intensity of Legend Biotech Corp to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Legend Biotech Corp (2018–2018)
Year-by-year capital reinvestment analysis for Legend Biotech Corp. For live market cap and broader valuation context, see Legend Biotech Corp stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.40x | $123.28 Million | $307.68 Million | $21.02 Million | — |